NEW YORK (GenomeWeb) – GenDx today said that its NGSgo-AmpX for amplifying complete HLA genes for downstream sequencing has received CE marking.

The amplification primers can be used for Sanger sequencing and certain next-generation sequencing approaches and is the first CE-marked product for HLA typing for NGS, GenDx said. The product is platform-agnostic and suitable for the Illumina MiSeq, Ion Torrent PGM, and PacBio RS systems, among others.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: spatiotemporal study of lncRNA expression, role of extrachromosomal, circular DNAs in yeast, and more.

A European team has launched a four-year study to develop a test to gauge cervical, ovarian, uterine, or aggressive breast cancer risk in women.

As interest in personalized medicine grows, government contractors are entering the field, the Washington Post reports.

In PLOS this week: Plasmodium knowlesi population genetics, oral microbiome of infants and children, and more.